Key statistics
As of last trade, Alvotech SA (Z45:FRA) traded at 4.21, 10.79% above the 52 week low of 3.80 set on Jan 08, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.18 |
|---|---|
| High | 4.21 |
| Low | 4.18 |
| Bid | 4.30 |
| Offer | 4.50 |
| Previous close | 4.11 |
| Average volume | 586.89 |
|---|---|
| Shares outstanding | 311.72m |
| Free float | 117.87m |
| P/E (TTM) | 24.56 |
| Market cap | 1.60bn USD |
| EPS (TTM) | 0.2093 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 14:25 GMT.
More ▼
Announcements
- Alvotech kynnir jákvæða niðurstöðu rannsóknar á lyfjahvörfum AVT80, fyrirhugaðrar hliðstæðu við líftæknilyfið Entyvio
- Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
- Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
- Alvotech gerir samninga um markaðssetningu á fyrirhuguðum hliðstæðum í Kanada, Ástralíu og Nýja-Sjálandi
- Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
- Alvotech nær samningum um alþjóðlega markaðssetningu hliðstæðu við augnlyfið Eylea
- Leiðrétting: Viðskipti stjórnenda og tengdra aðila
- Correction: Transactions of Managers and Closely Associated Persons
- Transactions of Managers and Closely Associated Persons
- Viðskipti stjórnenda og tengdra aðila
More ▼
